Skip to main content

AirSculpt® Technologies, Inc. Announces Plans to Open London Location in 2023

Written by Customer Service on . Posted in Public Companies.

Elite Body Sculpture London

Elite Body Sculpture's London Location Opening 2023
Elite Body Sculpture’s London Location Opening 2023

MIAMI BEACH, Fla., Dec. 13, 2022 (GLOBE NEWSWIRE) — AirSculpt® Technologies, Inc., (“AirSculpt”) (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced the opening of its first overseas Elite Body Sculpture location in London, England in the first half of 2023. AirSculpt now expects to open five office locations in 2023.

2022-12-13 -- AIRS -- Opening London Office

Elite Body Sculpture’s London Location Opening 2023

AirSculpt® is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at Elite Body Sculpture offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results.

“We are delighted to share that we will be opening our first overseas location during the first half of 2023,” said Dr. Aaron Rollins, Founder and Chief Executive Officer at AirSculpt® Technologies. “Our 51 Harley Street location will deliver, what we believe to be, the best solution to permanent body fat reduction in a luxury experience.” Rollins continued, “And we are thrilled to announce that Rana Das-Gupta has joined us as Medical Director. His experience and expertise within not only plastic surgery, but body fat reduction is impressive, and he will be an important asset to the team. We look forward to introducing our other surgeons in the coming weeks.”

Rana Das-Gupta is a well-established Consultant Plastic Surgeon based in England. He qualified from The London Hospital Medical College (University of London) and trained in General Surgery and Plastic Surgery predominantly in London teaching hospitals. He carried out a number of fellowships in the UK and Scandinavia before taking up a substantive post as an NHS Consultant Plastic Surgeon in 2004. Since that time, in parallel to a wide range of reconstructive surgery, he has carried out a full range of cosmetic surgery procedures across the field.

Investor Contact:

Steven Halper/Caroline Paul
Managing Directors, LifeSci Advisors
investors@elitebodysculpture.com

Media Contact:
Stephanie Evans Greene
Chief Marketing Officer
AirSculpt® Technologies, Inc.
sevansgreene@elitebodysculpture.com

About AirSculpt®
AirSculpt® Technologies (NASDAQ: AIRS) is an experienced, fast-growing international provider of body contouring procedures delivering a premium consumer experience under its brand, Elite Body Sculpture. At Elite Body Sculpture, we provide custom body contouring using our proprietary AirSculpt® method that removes unwanted fat in a minimally invasive procedure, producing dramatic results. It is our mission to generate the best results for our patients.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2cdbcfbb-7595-42d1-9976-f772f911a36c

 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.